MLH1 and neoplasm: Numerous TSGs have since been identified, including the likes of cell cycle inhibitors such as cyclin‐dependent kinase inhibitor 2 (CDKN2), DNA repair proteins such as MutL Homolog 1 (MLH1), angiogenesis blockers such as Von Hippel–Lindau (VHL) tumor suppressor, and cell adhesion molecules exemplified by CDH1 (cadherin‐1).93